cbdMD Inc
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
YCBD$0.38-8.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 6. Exhibits
| Incorporated by Reference · Filed or Furnished | |||||
|---|---|---|---|---|---|
| No. | Exhibit Description | Form | Date Filed | Number | Herewith |
| 2.1 | Merger Agreement dated December 3, 2018 by and among Level Brands, Inc., AcqCo, LLC, cbdMD LLC and Cure Based Development, LLC | 8-K | 12/3/18 | 2.1 | |
| 2.2 | Articles of Merger dated December 20, 2018 as filed with the Secretary of State of Nevada merging AcqCo, LLC with and into Cure Based Development, LLC | 10-Q | 2/14/19 | 2.2 | |
| 2.3 | Articles of Merger dated December 20, 2018 as filed with the Secretary of State of North Carolina merging AcqCo, LLC with and into Cure Based Development, LLC | 10-Q | 2/14/19 | 2.3 | |
| 2.4 | Articles of Merger dated December 20, 2018 as filed with the Secretary of State of Nevada merging Cure Based Development, LLC with an into cbdMD LLC | 10-Q | 2/14/19 | 2.4 | |
| 2.5 | Articles of Merger dated December 20, 2018 as filed with the Secretary of State of North Carolina merging Cure Based Development, LLC with an into cbdMD LLC | 10-Q | 2/14/19 | 2.5 | |
| 2.6 | Addendum No. 1 to Agreement and Plan of Merger dated March 31, 2021 | 8-K | 4/1/21 | 10.1 | |
| 3.1 | Articles of Incorporation | 1-A | 9/18/17 | 2.1 | |
| 3.2 | Articles of Amendment to the Articles of Incorporation – filed April 22, 2015 | 1-A | 9/18/17 | 2.2 | |
| 3.3 | Articles of Amendment to the Articles of Incorporation – filed June 22, 2015 | 1-A | 9/18/17 | 2.3 | |
| 3.4 | Articles of Amendment to the Articles of Incorporation – filed November 17, 2016 | 1-A | 9/18/17 | 2.4 | |
| 3.5 | Articles of Amendment to the Articles of Incorporation – filed December 5, 2016 | 1-A | 9/18/17 | 2.5 | |
| 3.6 | Articles of Amendment to Articles of Incorporation | 8-K | 4/29/19 | 3.7 | |
| 3.7 | Articles of Amendment to the Articles of Incorporation including the Certificate of Designations, Rights and Preferences of the 8.0% Series A Cumulative Convertible Preferred Stock | 8-A | 10/11/19 | 3.1(f) | |
| 3.8 | Articles of Amendment of Articles of Incorporation, as amended, of cbdMD, Inc. effective April 24, 2023 - reverse stock split | 8-K | 4/27/23 | 3.1 | |
| 3.9 | Bylaws, As amended | 1-A | 9/18/17 | 2.6 | |
| 4.1 | Form of Convertible Promissory Note dated January 30, 2024 | 8-K | 2/2/24 | 4.1 | |
| 10.1 | License Agreement, effective as of March 20, 2024, by and between cbdMD, Inc. and HSKL, Inc. | 8-K | 3/18/24 | 10.1 | |
| 10.2 | Lease Forbearance Agreement, dated as of March 14, 2024, by and between cbdMD, Inc. and HSKL, Inc. | 8-K | 3/18/24 | 10.2 | |
| 10.3 | Securities Purchase Agreement, dated as of January 30, 2024, by and between cbdMD, Inc. and the Investors+ | 8-K | 2/2/24 | 10.3 | |
| 10.4 | Security Agreement, dated as of January 30, 2024, by and between cbdMD, Inc. and the Investor+ | 8-K | 2/2/24 | 10.4 | |
| 10.5 | Registration Rights Agreement, dated January 30, 2024, by and between cbdMD, Inc. and the Investor | 8-K | 2/2/24 | 10.5 | |
| 31.1 | Certification of Principal Executive Officer and Principal Financial Officer (Section 302) | Filed | |||
| 32.1 | Certification of Principal Executive Officer and Principal Financial Officer (Section 906) | Furnished* | |||
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | Filed | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | Filed | |||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | Filed | |||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | Filed | |||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | Filed | |||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | Filed | |||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL Document and include in Exhibit 101) | Filed | |||
- Exhibits and/or schedules have been omitted. The Company hereby agrees to furnish to the staff of the Securities and Exchange Commission upon request any omitted information.
- This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.
Copies of this report (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our stockholders who make a written request to our Corporate Secretary at cbdMD, Inc. 2101 Westinghouse Blvd, Suite A, Charlotte, NC 28273.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| cbdMD, INC. | ||
| May 15, 2024 | By: | /s/ T. Ronan Kennedy |
|---|---|---|
| T. Ronan Kennedy, Chief Executive Officer and | ||
| principal executive officer | ||
| May 15, 2024 | By: | /s/ T. Ronan Kennedy |
| T. Ronan Kennedy, Chief Financial Officer and | ||
| principal financial officer | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.